Henry Schein, Inc.
HSIC
NASDAQ·Healthcare·Medical - Distribution·Mkt cap $10.1B
$88.52
▼ -1.43%
P/E
25.66
Mkt Cap
$10.1B
52-Wk Range
$61.95–$92.18
52-Week Range
$61.95 - $92.18
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 29.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive global distribution network
- Comprehensive product and service ecosystem
- Strong relationships with healthcare providers
- Vertical integration of distribution and technology services
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Digital healthcare transformation
Value
Attractively priced below Healthcare Distribution peer average
Momentum
Strong
+16.4% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying HSIC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 4, 2026
Reported EPS of $1.27 vs $1.24 consensus (+2.4% surprise). Revenue of $3.5B vs $3.4B expected (+2.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+2.4%
Revenue trend · last 8Q
—
+6%
-0%
+3%
+5%
+8%
+6%
+7%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$3.2B
$3.2B
$3.2B
$3.2B
$3.3B
$3.4B
$3.4B
$3.5B
Margins · last 8Q
Gross
—
Operating
—
Profit
2.7%
Wall Street consensus
8 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
38%
Sell
13%
Median Price Target
—
Latest: Barclays · Aug 6, 2026
vs Industry
How HSIC stacks vs Medical - Distribution
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related